Kim N, Seong J. Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?" J Hepatol 2020 May 25. pii: S0168-8278(20)30229.
PMID: 32467075